CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,297,000 | +459.1% | 142,007 | +846.7% | 0.02% | +500.0% |
| Q3 2021 | $232,000 | -77.4% | 15,000 | -79.2% | 0.00% | -76.9% |
| Q2 2021 | $1,027,000 | -88.7% | 72,100 | -82.8% | 0.01% | -93.4% |
| Q1 2021 | $9,089,000 | +892.2% | 418,710 | +503.4% | 0.20% | +276.9% |
| Q1 2020 | $916,000 | -56.7% | 69,395 | -47.2% | 0.05% | -27.8% |
| Q4 2019 | $2,117,000 | +231.3% | 131,400 | +275.4% | 0.07% | +118.2% |
| Q3 2019 | $639,000 | -92.6% | 35,000 | -91.2% | 0.03% | -92.4% |
| Q2 2019 | $8,598,000 | +678.8% | 400,000 | +611.1% | 0.43% | +608.2% |
| Q1 2019 | $1,104,000 | -77.0% | 56,250 | -71.9% | 0.06% | -76.9% |
| Q3 2018 | $4,790,000 | – | 200,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
| Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
| Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
| Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
| PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |